Sionna Therapeutics Inc (SION) Stock News

Pomerantz LLP is investigating potential securities fraud claims against Sionna Therapeutics following the company's August 10, 2026 announcement that its PreciSION CF Phase 2a trial failed to achieve its key activity endpoint. The failure to demonstrate efficacy of SION-719 when combined with Trikafta resulted in a dramatic 91.18% stock price decline, falling from approximately $51.04 to $4.50 per share.

Rocket Lab completed its 97th Electron launch, delivering the 13th StriX satellite for Synspective's Earth-monitoring constellation. The mission marks the 18th Rocket Lab launch in 2026, maintaining its position as the world's most frequently-launched small-lift orbital rocket. With 100% mission success across all 13 StriX deployments, Rocket Lab continues its multi-year partnership with Synspective, with 14 additional launches scheduled to complete the constellation by decade's end.

L'Oréal completed a successful bond issuance of €2 billion across three tranches on September 24, 2026: €850 million at 2 years with variable rate (Euribor 3M + 27 bp), €500 million at 3 years at 3.75% fixed, and €650 million at 7 years at 4.00% fixed. The bonds are expected to be rated AA (Stable) by S&P and Aa1 (Stable) by Moody's, with listing on Euronext Paris on September 30, 2026.

Rocket Lab successfully launched its 96th Electron rocket on September 19, 2026, delivering Synspective's 12th StriX Earth-observation satellite into precise 572km orbit. This marks Rocket Lab's 17th launch of 2026 and extends its 100% mission success record with Synspective, with 15 additional dedicated missions manifested through decade's end.

Sionna Therapeutics announced a 46% workforce reduction and major restructuring following the failure of SION-719 to meet its primary endpoint in a cystic fibrosis study. The company is shifting focus to its dual combination therapy SION-451 + SION-2222, which it plans to advance into phase IIa trials in 2027. The restructuring is expected to extend cash runway into the second half of 2029.

Avacta announced positive Phase 1 clinical data for AVA6103, its next-generation FAP-targeted peptide-drug conjugate, demonstrating a clean safety profile with controlled-release exatecan at doses 50% higher than conventional exatecan's MTD. Pharmacokinetic data aligned with preclinical predictions, and head-to-head preclinical comparisons showed AVA6103 delivered superior antitumor activity compared to marketed ADC Enhertu®, with deep and durable responses in all treated animals.

Law firm Bragar Eagel & Squire is investigating Sionna Therapeutics after the company announced its SION-719 Phase 2a trial failed to achieve its primary endpoint for sweat chloride reduction. The stock price fell over 91% following the announcement. The firm is encouraging affected shareholders to contact them regarding potential securities law violations.

Glancy Prongay Wolke & Rotter LLP is investigating Sionna Therapeutics for potential securities law violations following the company's announcement of a primary endpoint miss in its PreciSION CF Phase 2a trial on August 10, 2026. The news triggered a 91.2% stock price decline, falling from approximately $46.64 to $4.10 per share, prompting a class action lawsuit on behalf of affected shareholders.

The Law Offices of Frank R. Cruz is investigating Sionna Therapeutics for potential federal securities law violations following the company's announcement of a primary endpoint miss in its PreciSION CF Phase 2a trial on August 10, 2026. The news triggered a 91.2% stock price decline, falling from approximately $46.64 to $4.10 per share, causing significant investor losses.

Law Offices of Howard G. Smith is investigating potential securities fraud violations at Sionna Therapeutics, Lincoln Educational Services, and Flotek Industries on behalf of shareholders who suffered losses. Sionna's stock plummeted 91.2% following disappointing Phase 2a trial results and a decision not to advance its lead candidate.

Madonna performed at CLUB CONFESSIONS presented by MISTR during WorldPride Amsterdam on August 4, 2026, surprising fans with a special appearance by Kylie Minogue. The pair debuted a new version of 'Love Sensation' and performed 'Sorry' for the first time in over two decades. The event highlighted Madonna's continued support for the LGBTQ+ community and MISTR's free telemedicine platform offering HIV prevention and sexual healthcare services.

iBUYPOWER, a gaming PC system integrator with 25 years of experience, has expanded into the professional workstation market with a new line of prebuilt and custom systems. The company simultaneously enhanced its warranty coverage to three years for both parts and labor, up from two years previously. The workstation lineup ranges from $3,349 to $19,149 and features configurations with Intel Core Ultra, AMD Ryzen, and high-end GPU options including NVIDIA RTX PRO Blackwell.

Madonna returned to New York City to celebrate her No.1 album Confessions II through CLUB CONFESSIONS, an immersive nightlife experience presented in partnership with MISTR, a telemedicine platform providing free HIV prevention and sexual healthcare services. The event, held at Knockdown Center, featured performances by Stuart Price, Honey Dijon, and other artists, drawing celebrities from music, fashion, and entertainment while raising awareness for LGBTQ+ health initiatives.

Avcon Industries, a subsidiary of Butler National Corporation, has received two FAA Supplemental Type Certificates (STCs) for the Bombardier Challenger 604, 605, and 650 aircraft platforms. The certifications approve installation of fuselage underside rail mounting provisions and radome systems for sensors and mission equipment, expanding Avcon's special mission aircraft modification portfolio and positioning the Challenger platforms as attractive options for customers requiring greater range, endurance, and payload capacity.

Q1 Revenue Up 44% YoY; Same-Store Sales Up 29%; Adjusted EBITDA Turns Positive as Company Advances National Expansion Strategy EDMONTON, AB , June 1, 2026 /CNW/ - Dr. Phone Fix Canada Corporation (TSXV: DPF) ("Dr. Phone Fix" or the "Company"), one of Canada's fastest-growing and award-winning consumer electronics repair and resale platforms, today reported financial results for the three months ended March 31, 2026, and provided an update on recent corporate developments. The Company operates a network of 44 corporately owned stores across five Canadian provinces. Financial Results Summary (CAD) (all dollar amounts in 000's) Three Months Ended Mar 31, 2026 Three Months Ended Mar 31, 2025 Variance (%) Revenue 3,162 2,196 +44 % Gross Profit 1,621 1,210 +34 % Gross Margin 51.3 % 55.1 % -3.8 pp Operating Expenses (SG&A) 2,476 1,754 +41 % Adjusted EBITDA(1) 88 (13) n/m Cash 291 1,558 -81 % (1) See Non-GAAP Financial Measure towards the end of this document. "Q1 reflected continued progress in the execution of our strategy with revenue increasing 44% year-over-year and comparable-store sales increasing 29%, even in what is typically our seasonally weakest quarter," said Piyush Sawhney, Founder and Chief Executive Officer of Dr. Phone Fix. "We also delivered positive Adjusted EBITDA, generated positive operating cash flow, and continued to improve execution across our national network while integrating recently acquired locations and advancing our OEM, insurance, supplier, repair and certified pre-owned device programs." Mr. Sawhney continued, "We have spent the past year building the foundation for a national, carrier-neutral device lifecycle platform. Today, we have 44 corporately owned locations across five provinces, a growing pipeline of acquisition and greenfield opportunities, and a strategy focused on disciplined expansion and stronger unit-level economics throug

Mission Bank has expanded its Bakersfield-based Agricultural Lending Team by hiring three industry veterans: Relationship Managers John Etchison and Eric Schoenheide, and Relationship Associate Eliza Hernandez. The team brings nearly 75 years of combined experience in ag lending and will operate from the Downtown Bakersfield Business Banking Center under Ag Division Manager Rob Hallum. This marks the second new team added by Mission Bank in 2026.

Austin, Texas , May 26, 2026 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE MEDX HOLDINGS (MEDH) REPORTS EXCEPTIONAL Q1 2026 FINANCIALS: REVENUE SURGES, EXPANSION ON TRACK, AND CEO TO SPEAK AT HEMP BEVERAGE EXPO AUSTIN, Texas — May 26, 2026 — MedX Holdings, Inc. (OTC: MEDH ) (soon to be Dazed Inc., pending ticker symbol DAZE), a dynamic brands and acquisition company focused on the emerging hemp, cannabis, and hospitality industries, today announced its financial results for the first quarter ended March 31, 2026. The company is thrilled to report significant year-over-year revenue and gross profit growth, continued profitability, and major traction in its nationwide franchise expansion. Q1 2026 Financial Highlights: Accelerated Growth and Profitability The first quarter of 2026 reflects the power of MedX's strategic focus on high-margin branding, efficient operations, and calculated expansion. Key financial milestones from the Q1 2026 consolidated financial statements include: Solid Revenue Growth: Q1 2026 revenues reached $521,874, representing an impressive 52.7% increase compared to revenues of $341,711 in Q1 2025. Surging Gross Profit: Gross profit for the quarter climbed to $398,990, a 70.6% jump from the $233,793 reported in the same period last year. Sustained Profitability: The company maintained a positive bottom line, reporting a net income of $22,203 for the three months ended March 31, 2026. Expansion on Track: Bringing the "Third Place" to New Cities Following the momentum built in late 2025, ... Full story available on Benzinga.com

MedX Holdings announced Q1 2026 results with continued net profitability and debt reduction. The company is rebranding to Dazed Inc. (ticker: DAZE) and expanding with three new LazyDaze + Coffeeshop locations in San Marcos, Houston, and Baltimore. The company is also finalizing partnerships for Lazydaze Coffee and K-Cup products and capitalizing on cannabis's federal reclassification to Schedule III.

Austin, Texas, May 22, 2026 (GLOBE NEWSWIRE) -- MEDX HOLDINGS ANNOUNCES Q1 2026 HIGHLIGHTS, MULTI-CITY EXPANSION, AND CORPORATE ACTION TO REBRAND AS DAZED INC. (TICKER: DAZE) AUSTIN, Texas — May 22, 2026 — MedX Holdings, Inc. (OTC: MEDH ), a leader in the converging cannabis, hemp, and hospitality sectors, today announced its operational and financial highlights for the first quarter of 2026. Building on the net profitability achieved in Q4 2025, the company continues to execute its aggressive expansion strategy, marked by upcoming store openings, strategic product partnerships, and a major corporate rebranding initiative to align with its rapidly growing consumer footprint. Corporate Action: Rebranding to Dazed Inc. To align the company's corporate identity with its flagship consumer brands and long-term vision, MedX Holdings has announced its intention and initiated the required corporate actions to change its name to Dazed Inc. Alongside this name change, the company intends to request a formal ticker symbol change to DAZE . This strategic evolution reflects the company's dominant focus on scaling the Lazydaze franchise ecosystem and Dazed Distribution networks. Q1 Financial and Operational Milestone Highlights Continued Debt Reduction: MedX sustained its disciplined focus on balance sheet strength, further paring down long-term liabilities throughout Q1 to enhance cash flow and shareholder equity. Lazydaze Coffee & K-Cup Partnerships: The company is currently in the final stages of talks with potential strategic partners to massively scale ... Full story available on Benzinga.com

CU Inc. announced that holders of Series 4 Preferred Shares will not be able to convert into Series 5 Preferred Shares, as only approximately 625 shares were tendered for conversion against the required one million shares threshold. The Series 4 Preferred Shares will continue paying a fixed quarterly dividend at an annual rate of 4.573% for the five-year period beginning June 1, 2026.

Chicago Rivet & Machine Co. (CVR) announced a temporary suspension of its quarterly cash dividend to redirect capital toward operational efficiencies, meeting production requirements, building its sales pipeline, and long-term growth initiatives. The company is prioritizing investments in production capacity, new product launches, and business development resources.

JE Cleantech Holdings Ltd (NASDAQ: JCSE) reported improved financial performance for 2025 with revenue of S$20.3 million, net income of S$3.2 million (up from S$0.03 million), and adjusted EBITDA of S$4.7 million (up 108%). Gross profit margin improved to 28.5% from 26.9%, driven by higher-margin sales of precision cleaning systems. Both business segments showed year-on-year growth.

Trio Petroleum Corp announced it has raised approximately $24 million through its ATM equity program, strengthening its balance sheet. The company is now pursuing a growth strategy focused on acquiring Canadian oil and gas assets, which management believes offer attractive valuations and operational upside. The CEO emphasized the company has transitioned from stabilization to execution phase and is urging stockholder support at the May 21, 2026 annual meeting.